Indefinite Delivery Contract SPM20005D2012

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $999,999,999.00 through December 2025, is the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Under this IDC, Amerisourcebergen receives numerous delivery orders to provide a diverse assortment of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials. The IDC, which does not have any set-aside designations, enables the DLA to efficiently procure these vital healthcare supplies for the Department of Defense and other federal agencies as needed. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

The provided task orders demonstrate the breadth of products supplied by Amerisourcebergen under this IDC, encompassing a wide range of pharmaceutical and medical items delivered to TRICARE facilities in the South region. These task orders, issued on a firm fixed-price basis, cover a diverse set of medications and supplies with ceiling values ranging from a few dollars up to over $35,000. The concentrated nature of the place of performance in Chesterbrook, Pennsylvania highlights Amerisourcebergen's ability to efficiently fulfill these government orders from its centralized distribution network.